TMPRSS2-ERG in blood and docetaxel resistance in metastatic castration-resistant prostate cancer

O Reig, M Marín-Aguilera, G Carrera, N Jimenez… - European urology, 2016 - Elsevier
TMPRSS2-ERG rearrangement is a genetic alteration exclusive to prostate cancer,
associated with taxane resistance in preclinical models. Its detection in blood samples of …
被引用次数：85 相关文章

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

Ò Reig, M Marín-Aguilera, G Carrera… - European …, 2016 - pubmed.ncbi.nlm.nih.gov
TMPRSS2-ERG rearrangement is a genetic alteration exclusive to prostate cancer,
associated with taxane resistance in preclinical models. Its detection in blood samples of …

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

Ò Reig, M Marín-Aguilera, G Carrera, N Jiménez… - European Urology, 2016 - infona.pl
TMPRSS2-ERG rearrangement is a genetic alteration exclusive to prostate cancer,
associated with taxane resistance in preclinical models. Its detection in blood samples of …

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer.

Ò Reig, M Marín-Aguilera, G Carrera, N Jiménez… - European …, 2016 - europepmc.org
TMPRSS2-ERG rearrangement is a genetic alteration exclusive to prostate cancer,
associated with taxane resistance in preclinical models. Its detection in blood samples of …
[PDF] rvaprostatecancersupport.org

[PDF][PDF] TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

O Reig, M Marın-Aguilera… - EUROPEAN …, 2016 - rvaprostatecancersupport.org
TMPRSS2-ERG rearrangement is a genetic alteration exclusive to prostate cancer,
associated with taxane resistance in preclinical models. Its detection in blood samples of …